It is going to be a few more months before Maia can compete again because the fighter has accepted a six month suspension from the United States Anti-Doping Agency (USADA) after testing positive for taking prohibited substances from a contaminated dietary supplement.
The following press release was issued by USADA on the matter:
January 15, 2019
USADA announced today that Jennifer Maia, of Curitiba, Brazil, has accepted a six-month sanction for a violation of the UFC Anti-Doping Policy after testing positive for prohibited substances from a contaminated dietary supplement.
Maia, 30, tested positive for furosemide, hydrochlorothiazide, chlorothiazide, and the thiazide metabolite 4-amino-6-chloro-1,3-benzenedisulfonamide (ACB), following an out-of-competition test conducted on August 16, 2018. These substances are Specified Substances in the class of Diuretics and Masking Agents and are prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List.
During an investigation into the circumstances of her case, opened and sealed containers of a dietary supplement she was using at the time of the August 16, 2018 sample collection, and that she declared on her doping control form, were sent to the WADA-accredited laboratory in Brazil for analysis. Although no prohibited substances were listed on the supplement label, the analysis revealed that both contained the prohibited substances for which Maia tested positive. Accordingly, this product has been added to the High Risk List of supplements maintained on USADA’s online dietary supplement safety education and awareness resource – Supplement 411 (www.Supplement411.org). Further, USADA reminds athletes that dietary supplement products marketed for weight loss carry significant risk to contain prohibited prescription medications, such as diuretics.
Under the UFC Anti-Doping Policy, as well as the World Anti-Doping Code, the determination that an athlete’s positive test was caused by a contaminated product may result in a reduced sanction. The sanction for a doping offense resulting from the use of a contaminated product ranges from a reprimand and no period of ineligibility to a two-year period of ineligibility.
Maia’s six-month period of ineligibility began on August 31, 2018, the date on which she was provisionally suspended from competition. Pursuant to the UFC Anti-Doping Policy, all UFC athletes serving a period of ineligibility for an anti-doping policy violation are required to continue to make themselves available for testing to receive credit for time completed under their sanction.
USADA conducts the year-round, independent anti-doping program for all UFC athletes. USADA is an independent, non-profit, non-governmental agency whose sole mission is to preserve the integrity of competition, inspire true sport, and protect the rights of clean athletes. In an effort to aid UFC athletes, as well as their support team members, in understanding the rules applicable to them, USADA provides comprehensive instruction on the UFC Anti-Doping Program website (https://UFC.USADA.org) regarding the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (https://UFC.GlobalDRO.com), conducts educational sessions, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, and periodic athlete alerts.
Along with education and testing, robust anti-doping programs enable investigations stemming from tips and whistleblowers. USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by email at [email protected], by phone at 1 877-Play Clean (1-877-752-9253), or by mail.
The suspension is retroactive to the date of the failed out of competition drug test, meaning Maia can return to action in early March.
